Revista de Chimie · 2019 · 20 citations · 0 references
MedicineNephrologyPharmacotherapyRenal PathophysiologyRenal PharmacotherapyRenal Replacement TherapyBlood Pressure ControlBlood Pressure ManagementBlood Pressure RegulationChronic Kidney DiseaseHypertension ManagementRenal DiseaseBlood PressureChronic Kidney Disease ManagementHypertension In CkdHypertension In Kidney Disease
The treatment of HTA plays a central part in the management of Chronic Kidney Disease (CKD) in all its stages, especially in patients following a substitute treatment of renal functions. HBP can be both the cause and the consequence of CKD. The HBP control in CKD patients represents one of the most important concerns of clinicians. HBP treatment is non pharmacological as well as pharmacological.